IRIS
MIGLIACCIO, Antimo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 9.598
NA - Nord America 5.606
AS - Asia 4.461
SA - Sud America 589
Continente sconosciuto - Info sul continente non disponibili 407
AF - Africa 51
OC - Oceania 10
Totale 20.722
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 5.876
US - Stati Uniti d'America 5.520
SG - Singapore 1.407
IE - Irlanda 1.019
CN - Cina 967
IT - Italia 835
HK - Hong Kong 625
BR - Brasile 492
UA - Ucraina 488
VN - Vietnam 462
GB - Regno Unito 444
DE - Germania 300
TR - Turchia 298
IN - India 278
KR - Corea 200
FI - Finlandia 193
SE - Svezia 123
FR - Francia 86
GR - Grecia 81
JP - Giappone 79
CA - Canada 46
BE - Belgio 44
AR - Argentina 38
BD - Bangladesh 28
NL - Olanda 23
MX - Messico 21
ID - Indonesia 18
IQ - Iraq 15
PK - Pakistan 15
PL - Polonia 14
AT - Austria 13
EC - Ecuador 13
ES - Italia 13
ZA - Sudafrica 13
CO - Colombia 12
VE - Venezuela 11
JO - Giordania 10
IR - Iran 8
MA - Marocco 8
PY - Paraguay 8
EG - Egitto 7
PH - Filippine 7
SA - Arabia Saudita 7
UZ - Uzbekistan 7
BG - Bulgaria 6
CZ - Repubblica Ceca 6
TH - Thailandia 6
AE - Emirati Arabi Uniti 5
AU - Australia 5
UY - Uruguay 5
CL - Cile 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
HU - Ungheria 4
KE - Kenya 4
NO - Norvegia 4
NZ - Nuova Zelanda 4
PA - Panama 4
TN - Tunisia 4
ET - Etiopia 3
HR - Croazia 3
IL - Israele 3
JM - Giamaica 3
LT - Lituania 3
PE - Perù 3
PT - Portogallo 3
SN - Senegal 3
TW - Taiwan 3
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
CI - Costa d'Avorio 2
DK - Danimarca 2
LV - Lettonia 2
MK - Macedonia 2
NP - Nepal 2
RO - Romania 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AO - Angola 1
AZ - Azerbaigian 1
BM - Bermuda 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CH - Svizzera 1
CR - Costa Rica 1
DM - Dominica 1
EE - Estonia 1
EU - Europa 1
GA - Gabon 1
GE - Georgia 1
GY - Guiana 1
HN - Honduras 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
Totale 20.311
Salva come PNG Salva come JPEG
Città #
Moscow 2.141
Dublin 1.012
San Jose 754
Jacksonville 747
Chandler 718
Singapore 693
Santa Clara 631
Hong Kong 611
Bengaluru 246
Ashburn 242
Ann Arbor 206
Seoul 186
Beijing 167
Ho Chi Minh City 161
Princeton 144
Hefei 143
Naples 137
Caserta 129
Hanoi 115
Boardman 109
Medford 109
Roxbury 88
Istanbul 83
Wilmington 82
Bremen 75
Los Angeles 74
Woodbridge 73
Dallas 72
San Mateo 60
The Dalles 49
Brussels 44
Nanjing 44
São Paulo 43
Helsinki 40
Cambridge 37
New York 37
Da Nang 35
Aversa 33
Rome 33
Houston 31
Munich 30
Jinan 29
Mountain View 28
Des Moines 26
Napoli 25
Turku 25
Rio de Janeiro 23
Pozzuoli 21
Nanchang 20
Shenyang 20
Kunming 18
Norwalk 17
Orem 17
Frankfurt am Main 15
Haiphong 14
Milan 14
Tokyo 14
Afragola 13
Frattamaggiore 13
Guangzhou 13
Atlanta 12
Biên Hòa 12
Chennai 12
Council Bluffs 12
Seattle 12
Shanghai 12
Belo Horizonte 11
Chicago 11
Hải Dương 11
London 11
Marano 11
Memphis 11
Toronto 11
Zhengzhou 11
Amsterdam 10
Somma Vesuviana 10
Vienna 10
Warsaw 10
Boston 9
Hanover 9
Salerno 9
Amman 8
Columbus 8
Dhaka 8
Falkenstein 8
Thái Nguyên 8
Tianjin 8
Tricesimo 8
Denver 7
Düsseldorf 7
Giugliano in Campania 7
Hangzhou 7
Manchester 7
Phoenix 7
Tashkent 7
Viterbo 7
Volla 7
Auburn Hills 6
Brooklyn 6
Cabo Frio 6
Totale 11.193
Salva come PNG Salva come JPEG
Nome #
Bisphenol A induces cell cycle arrest in primary and prostate cancer cells through EGFR/ERK/p53 signaling pathway activation. 301
'Role of PI3-K signaling in steroid action’ 215
CROSS-TALK BETWEEN ANDROGEN RECEPTOR AND NERVE GROWTH FACTOR RECEPTOR IN PROSTATE CANCER CELLS: IMPLICATIONS FOR A NEW THERAPEUTIC APPROACH. 200
A 67 kDa non-hormone binding estradiol receptor is present in human mammary cancers 198
Inhibition of p110δ PI3K prevents inflammatory response and restenosis after artery injury. 197
Androgen regulation of motility in fibroblasts 196
Polyproline and Tat transduction peptides in the study of the rapid actions of steroid receptors 188
Calmodulin-stimulated estradiol receptor-tyrosine kinase I 186
Breast cancer stem cells: The role of sex steroid receptors 186
Role of atypical protein kinase C in estradiol-triggered G1/S progression of MCF-7 cells 185
Androgen-stimulated DNA synthesis and cytoskeletal changes in fibroblasts by a nontranscriptional receptor action. 184
Inhibition of the SH3 domain-mediated binding of Src to the androgen receptor and its effect on tumor growth 181
Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor. 180
CROSS TALK BETWEEN ANDROGEN RECEPTOR/ FILAMIN A AND TrkA REGULATES NEURITE OUTGROWTH IN PC12 CELLS 180
Androgen-induced cell migration: role of androgen receptor/filamin A association. 179
Activation-inactivation of hormone binding sites of the oestradiol-17 beta receptor is a multiregulated process 178
Recent advances on bisphenol-A and endocrine disruptor effects on human prostate cancer 174
Integrating signals between cAMP and MAPK pathways in breast cancer 172
Crosstalk between EGFR and extranuclear steroid receptors. 172
Sex steroid hormones act as growth factors 170
Analysis of androgen receptor rapid actions in cellular signaling pathways: receptor/src association 170
Protein tyrosine phosphorylation and estradiol action 169
Targeting rapid action of sex-steroid receptors in breast and prostate cancers. 169
PI3-kinase in concert with Src promotes the S-phase entry of oestradiol-stimulated MCF-7 cells. 168
Inhibition of estradiol receptor/Src association and cell growth by an estradiol receptor a alpha tyrosine-phosphorylated peptide 166
Activation of the Src/Ras/Erks pathway is required for steroid-induced S-phase entry of human mammary carcinoma-derived cells 166
Androgens Induce Invasiveness of Triple Negative Breast Cancer Cells through AR/Src/PI3-K Complex Assembly. 166
Epigenetic drugs against cancer: an evolving landscape. 165
Discovering New Targets in Triple-Negative Breast Cancer (TNBC): The Androgen Receptor and the Estrogen Receptor β. 164
Agri-Food By-Products in Cancer: New Targets and Strategies. 164
'Steroid-activated PI3-K pathway in target cells'. 163
Advances in Rapid Sex-Steroid Action New Challenges and New Chances in Breast and Prostate Cancers 163
Action of vanadate on estrogen dependent MCF-7 cells. 162
Steroid induced androgen receptor-oestardiol receptor ß- Src complex triggers prostate cancer cell proliferation 161
Analysis of histone posttranslational modifications in the control of chromatin plasticity observed at estrogen-responsive sites in human breast cancer cells. 159
Activation of c-src/p21ras/erks pathway by steroids and its role in human mammary cancer cell lines. 159
THE DUAL ROLE OF ANDROGEN RECEPTOR IN MESENCHYMAL CELLS. 158
Rapid signalling pathway activation by androgens in epithelial and stromal cells 158
Estradiol activation of human colon carcinoma-derived Caco-2 cell growth 156
Activation of Src/Ras/Erks sgnalling pathway is required for steroid-induced DNA synthesis 156
Phosphoinositide 3-kinase assay in breast cancer cell extracts. 154
EXTRA-NUCLEAR PARTNERS OF ANDROGEN RECEPTOR: AT THE CROSSROADS OF PROLIFERATION, MIGRATION AND NEURITOGENESIS. 151
Src is an initial target of sex steroid hormone action. 150
Estrogen Receptors in Epithelial-Mesenchymal Transition of Prostate Cancer. 150
Communication between cells: exosomes as a delivery system in prostate cancer. 150
ERβ in Triple-Negative Breast Cancer: Emerging Concepts and Therapeutic Possibilities 150
Androgens and NGF Mediate the Neurite-Outgrowth through Inactivation of RhoA. 149
Phosphorylation on tyrosine of in vitro synthesized human estrogen receptor activates its hormone binding 149
In vitro phosphorylation and hormone binding activation of the synthetic wild type human estradiol receptor 149
Cell proliferation regulated by estradiol receptor: therapeutic implications. 149
Role of the Androgen Receptor in Gender-Related Cancers. 148
The Androgen Regulation of Matrix Metalloproteases in Prostate Cancer and Its Related Tumor Microenvironment. 147
Binary switch between adjacent marks in histone H3 directs productive transcription in estrogen-induced breast cancer cells upon cyclical creation of ROS. 147
Role of non-genomic androgen signalling in suppressing proliferation of fibroblasts and fibrosarcoma cells. 146
A Small Peptide Targeting the Ligand-Induced Androgen Receptor/Filamin a Interaction Inhibits the Invasive Phenotype of Prostate Cancer Cells 144
The Role of the Androgen Receptor in Skeletal Muscle and Its Utility as a Target for Restoring Muscle Functions. 143
Androgens as the “old age stick” in skeletal muscle (Correction: Androgens as the “old age stick” in skeletal muscle) 141
BRD9 binds cell type-specific chromatin regions regulating leukemic cell survival via STAT5 inhibition 141
Estrogens Modulate Somatostatin Receptors Expression and Synergizes With the Somatostatin Analog Pasireotide in Prostate Cells 140
Steroid receptor regulation of epidermal growth factor signaling through Src in breast and prostate cancer cells: steroid antagonist action. 139
Steroid signaling activation and intracellular localization of sex steroid receptors 138
Filamin A cooperates with the androgen receptor in preventing skeletal muscle senescence 137
Cross talk between epidermal growth factor (EGF) receptor and extra nuclear steroid receptors in cell lines. 137
Control of cell proliferation by estradiol and protein tyrosine phosphorilation. 137
Phosphorylation on tyrosine of oestradiol-17 beta receptor in uterus and interaction of oestradiol-17 beta and glucocorticoid receptors with antiphosphotyrosine antibodies 135
Prostate cancer stem cells: the role of androgen and estrogen receptors. 135
Phosphorylation of H3 serine 10 by IKKα governs cyclical production of ROS in estrogen-induced transcription and ensures DNA wholeness. 132
Tyrosine phosphorylation of estradiol receptor by Src regulates its hormone-dependent nuclear export and cell cycle progression in breast cancer cells. 132
The androgen receptor in breast cancer 132
Targeting the Nerve Growth Factor Signaling Impairs the Proliferative and Migratory Phenotype of Triple-Negative Breast Cancer Cells. 131
New insights and emerging therapeutic approaches in prostate cancer. 129
The role of estradiol receptor in the proliferative activity of vanadate on MCF-7 cells 128
The role of androgen receptor/filamin A association in androgen-induced cell migration 128
Exosomes: Emerging Modulators of Pancreatic Cancer Drug Resistance 127
Filamin A in triple negative breast cancer. 127
THE ROLE OF THE ANDROGEN RECEPTOR IN SKELETAL MUSCLE SENESCENCE. 126
Targeting androgen receptor/Src complex impairs the aggressive phenotype of human fibrosarcoma cells. 125
New TRPM8 blockers exert anticancer activity over castration-resistant prostate cancer models. 125
The role of androgen receptor in stromal cells. 124
ICI 164,384 e ICI 182,780 prevengono l’atività proliferativa del recettore dell’estradiolo mediata dalla fosforilazione delle proteine. 124
Novel aspects of signalling activation by steroid hormones in target cells. 124
Non-genomic action of steroid hormones: More questions than answers 123
Acetylation/methylation at lysine 9 in histone H3 as a mark of nucleosome asymmetry in human somatic breast cells 123
Epidermal growth factor induces protein tyrosine phosphorylation and association of p190 with ras-GTP-ase activating protein in Caco-2 cells. 122
The HDAC inhibitor SAHA regulates CBX2 stability via a SUMO-triggered ubiquitin-mediated pathway in leukemia 122
Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol receptor complex in MCF-7 cells 120
Inhibitors targeting the Src/Ras/Erks pathway prevent cancer cell S-phase entry induced by steroids. 120
Dephosphorylation of oestradiol nuclear receptor in vitro. A hypothesis on the mechanism of action of non-steroidal anti-oestrogens 118
Phosphorylation of uterus estradiol receptor on tyrosine 117
Nerve Growth Factor Induces Proliferation and Aggressiveness In Prostate Cancer Cells. 117
P491 THE ANDROGEN RECEPTOR IN HUMAN SKELETAL MUSCLE BIOPSIES 116
Two domains of the progesterone receptor interact with the estrogen receptor and are required for progesterone activation of the c-Src/Erk pathway in mammalian cells 115
Protein tyrosine phosphorylation and estradiol action 115
Steroid activation of signal transducing pathways. 114
Non-transcriptional action of oestradiol and progestin triggers DNA synthesis. 113
Therapeutic potential of TRPM8 antagonists in prostate cancer. 113
NON-GENOMIC ANDROGEN ACTION REGULATES PROLIFERATIVE/MIGRATORY SIGNALLING IN STROMAL CELLS. 112
Direct evidence of in vitro phosphorylation-dephosphorylation of the estradiol-17 beta receptor. Role of Ca2+-calmodulin in the activation of hormone binding sites 111
The androgen receptor/filamin A complex as a target in prostate cancer microenvironment. 110
The role of androgen receptor/filamin A association in androgen-induced cell migration. 109
Totale 14.964
Salva come PNG Salva come JPEG
Categoria #
all - tutte 68.834
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.834
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022971 0 11 13 30 341 36 27 28 33 91 88 273
2022/20232.338 161 67 36 243 230 234 10 174 1.047 25 60 51
2023/2024967 102 40 29 62 279 51 47 55 13 50 101 138
2024/20252.514 18 25 33 142 381 344 411 185 314 288 199 174
2025/202610.507 468 702 457 409 839 5.506 614 527 446 266 148 125
2026/202778 64 14 0 0 0 0 0 0 0 0 0 0
Totale 20.722